USANA Health Sciences, Inc.
USNA
$17.13
-$0.01-0.06%
NYSE
| 01/03/2026 | 09/27/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.86% | -9.40% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.86% | -9.40% | |||
| Cost of Revenue | 1.21% | -2.73% | |||
| Gross Profit | 7.24% | -11.21% | |||
| SG&A Expenses | -2.50% | -3.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.65% | -3.05% | |||
| Operating Income | 1,309.23% | -92.68% | |||
| Income Before Tax | 132.83% | -90.47% | |||
| Income Tax Expenses | -31.74% | 0.99% | |||
| Earnings from Continuing Operations | 76.06% | -163.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -228.57% | 117.74% | |||
| Net Income | 72.78% | -167.55% | |||
| EBIT | 1,309.23% | -92.68% | |||
| EBITDA | 182.29% | -62.62% | |||
| EPS Basic | 72.79% | -168.36% | |||
| Normalized Basic EPS | 758.35% | -88.37% | |||
| EPS Diluted | 73.06% | -169.23% | |||
| Normalized Diluted EPS | 758.35% | -88.36% | |||
| Average Basic Shares Outstanding | 0.05% | -1.19% | |||
| Average Diluted Shares Outstanding | 0.05% | -1.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||